Rees L, Greene S A, Rigden S P, Haycock G B, Chantler C, Preece M A
Division of Paediatrics, United Medical School Guy's Hospital, London, UK.
Pediatr Nephrol. 1990 Mar;4(2):160-2. doi: 10.1007/BF00858829.
Eleven boys, mean age 15.3 years (range 13.2-17.5), with pubertal delay in association with steroid therapy for steroid-sensitive nephrotic syndrome and following renal transplantation were treated with oxandrolone 2.5 mg daily for a mean of 0.50 years (range 0.34-0.61). Mean growth velocity increased from 3.9 cm/year (range 1.1-6.3) to 6.1 cm/year (range 2.0-14.4) and was maintained at 6.1 cm/year (range 0.4-10.2) (P less than 0.05). However, there was no significant difference in growth between the treated boys and age- and puberty-matched controls. Elevation of blood cyclosporin A and creatinine levels occurred in the transplant patients. Oxandrolone may initiate a pubertal growth spurt in patients taking steroid therapy for renal disease, but should be used with extreme caution because of potential side-effects.
11名男孩,平均年龄15.3岁(范围13.2 - 17.5岁),因类固醇敏感性肾病综合征接受类固醇治疗以及肾移植后出现青春期延迟,接受氧雄龙治疗,每日2.5毫克,平均治疗0.50年(范围0.34 - 0.61年)。平均生长速度从3.9厘米/年(范围1.1 - 6.3)增至6.1厘米/年(范围2.0 - 14.4),并维持在6.1厘米/年(范围0.4 - 10.2)(P小于0.05)。然而,接受治疗的男孩与年龄及青春期匹配的对照组之间在生长方面无显著差异。移植患者出现血环孢素A和肌酐水平升高。氧雄龙可能会使接受肾病类固醇治疗的患者出现青春期生长突增,但由于存在潜在副作用,应极其谨慎使用。